
Mindstate Design Labs
Mindstate Design Labs is a YC Summer 2021 (S21) company. Based in San Francisco, CA, USA. Team of 7.
About Mindstate Design Labs
Summary
Mindstate Design Labs builds a clinical-stage drug discovery platform that engineers specific psychoactive states, such as clarity, empathy, and awe, into pharmaceutical form. Its Osmanthus platform uses AI to map receptor-level pharmacology onto high-dimensional experiential data, translating first-person descriptions of mental states into quantitative molecular design targets. The pipeline replaces broad-spectrum psychiatric drugs with precisely profiled compounds designed to produce targeted emotional and cognitive effects without hallucinations.
From the Y Combinator listing
Clinical-stage AI neuroengineering platform
We're making every therapeutically valuable emotion available on demand in pharmaceutical form. Our Osmanthus platform is an ensemble of AI models that synthesize the world’s largest datasets of psychoactive pharmacology and phenomenology, quantitatively pinpointing the combination of neurotransmitter receptor activity that underlies various emotional as well as cognitive and perceptual states. Our lead program MSD-001 is designed to be rapid-acting and produce heightened emotional and cognitive flexibility without hallucinations. MSD-001 is currently in human trials, and will be the base ingredient for multiple drug combination "emotions in a bottle" such as empathy, awe, clarity, or beauty.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 7
- Active
- Early
Founders (2)
- Tom Ray
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works